魯北化工(600727.SH):簽訂戰略投資合作協議
格隆匯11月22日丨魯北化工(600727.SH)公佈,公司、山東祥海鈦資源科技有限公司(簡稱“祥海科技”)與濟南域瀟集團有限公司(簡稱“域瀟集團”)、張順成、張遠良及內蒙古域瀟蒙達鈦業有限責任公司(簡稱“蒙達鈦業”)於2024年11月22日簽訂了《戰略投資合作協議》(簡稱“本協議”),各方經平等自願協商,就祥海科技對蒙達鈦業增資及建立長期穩定的鈦精礦、高鈦渣供需關係達成本協議,並以此作為本次投資合作的指引,以資共同信守。
《戰略投資合作協議》的簽訂符合公司向上遊鈦精礦、高鈦渣進行整合的戰略發展規劃,有利於公司穩定高鈦渣、鈦精礦的原料供應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.